0001143313-23-000074.txt : 20231002
0001143313-23-000074.hdr.sgml : 20231002
20231002144150
ACCESSION NUMBER: 0001143313-23-000074
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20231002
DATE AS OF CHANGE: 20231002
EFFECTIVENESS DATE: 20231002
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GSK plc
CENTRAL INDEX KEY: 0001131399
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15170
FILM NUMBER: 231299094
BUSINESS ADDRESS:
STREET 1: 980 GREAT WEST ROAD
CITY: BRENTFORD MIDDLESEX
STATE: X0
ZIP: TW8 9GS
BUSINESS PHONE: 011442080475000
MAIL ADDRESS:
STREET 1: 980 GREAT WEST ROAD
CITY: BRENTFORD MIDDLESEX
STATE: X0
ZIP: TW8 9GS
FORMER COMPANY:
FORMER CONFORMED NAME: GSK PLC
DATE OF NAME CHANGE: 20220516
FORMER COMPANY:
FORMER CONFORMED NAME: GLAXOSMITHKLINE PLC
DATE OF NAME CHANGE: 20010105
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001131399
GSK plc
001-15170
980 GREAT W RD
Brentford
TW8 9GS
+44 20 8047 5000
Guarantor of the 0.534% Notes due 2023
17 CFR 240.12d2-2(a)(2)
Daniel Contrastano
Manager, Market Watch & Proxy Compliance
2023-10-02
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the guarantor of the stated securities from listing and registration on the Exchange at the opening of business on October 13, 2023, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(2) That the entire class of this security was redeemed or paid at maturity or retirement on October 02, 2023.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on October 02, 2023.